Programme and Abstract - fluoron
Programme and Abstract - fluoron
Programme and Abstract - fluoron
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Programme</strong> <strong>and</strong> <strong>Abstract</strong>s for HEATAM 3 meeting<br />
21st November 2009<br />
1
<strong>Programme</strong><br />
Schedule Speaker Title Affiliation Duratio Duration<br />
n of talk of<br />
discussio<br />
n<br />
0900-0903 Session 1: Indications - Chairperson Bernd Kirchhof (Welcome) / Time keeper (David<br />
Wong)<br />
0903-0910 Alex<strong>and</strong>ra<br />
Lappas<br />
Treatment of macular hole with heavy oil Cologne 7 min defer<br />
0910-0917 Peter Stalman Macular Hole Surgery With Inner Limiting<br />
Membrane Peeling, Endodrainage, <strong>and</strong> Heavy<br />
Silicone Oil Tamponade<br />
Leuven 7 min defer<br />
0917-0924 Barbara Parolini Posterior retinal detachment due to macular<br />
hole in high myopia, 25 cases treated with<br />
densiron <strong>and</strong> 17 with silicone oil 1000<br />
Negrar-<br />
Verona<br />
0924-0936 Bernd Kirchhof Panel discussion : to summarise rationale, evidence, complications<br />
<strong>and</strong> justification of macular hole using HSO<br />
7 min defer<br />
12 min<br />
0936-0943 Heinrich Heimann Is Heavy Oil helpful for PVR? Liverpool 7 min defer<br />
0943-0949 K.A. Becker Retrospective analysis of 67 patients with<br />
heavy silicone oil tamponade<br />
Chemnitz 6 min defer<br />
0949-0956 Katerine<br />
Engelmann<br />
Primary vitrectomy using heavy oil Chemnitz 7 min defer<br />
0956-1003 Murat Oncel Long term results of safety <strong>and</strong> efficacy of<br />
heavy oils<br />
Istanbul 7 min defer<br />
1003-1010 Cesare Forlini HSO as 1st choice in complicated retinal<br />
detachment: checkmate in two moves<br />
Ravenna 7 min defer<br />
1010-1020 Antonia Joussen HSO study an update Dusseldorf 10 min defer<br />
1020-1030 Discussion of above papers 10 min<br />
1030-1100 Coffee Break<br />
1100-1130 Motion of the debate: “There is no need for heavy oil, not now, not ever”<br />
speaking against the motion will be Claus Eckardt <strong>and</strong> speaking for the<br />
motion will be Norbert Bornfeld<br />
Session 2: Techniques - Chairperson Stanislao Rizzo<br />
30 min<br />
1130-1137 Hon Woon Giant retinal tears without PFCL Leeds 7 min defer<br />
1137-1144 Thomas Theelen “Hydraulic jump to heavy oil in retinal<br />
detachment surgery - no need for heavy<br />
liquids”<br />
Nijmegen 7 min defer<br />
1144-1150 Discussion of above 2 papers 6 min<br />
1150-1155 David Steel Removal of heavy oil combined with cataract<br />
surgery<br />
Sunderl<strong>and</strong> 5 min defer<br />
1155-1200 Xavier<br />
Removal of heavy oil from the limbus under Barcelona 5 min defer<br />
Valldeperas topical anaesthesia<br />
1200-1205 Theodor Stappler Tubeless syphon Liverpool 5 min defer<br />
1205-1210 Mario Romano Removal of Densiron-68 with 23-Gauge<br />
transconjunctival vitrectomy System. How is it<br />
possible?<br />
Milan 5 min defer<br />
1210-1220 Discussion of above papers 10 min<br />
1220-1230 Stefano Zenoni Combination of tamponade Bergamo 5 min 5 min<br />
1230-1245 Andrew Chang The use of PFCL as temporary tamponade Sydney 10 min 5 min<br />
1245-1300 Carlos Mateo The use of Haelon in vitreoretinal surgery Barcelona 10 min 5 min<br />
1300-1400 Lunch<br />
2
1415 Session 3: New Substances : Chairperson Heinrich Heimann<br />
1415-1420 Rachel Williams Theory behind emulsified resistant oils Liverpool 5 min defer<br />
1420-1425 Albert Caramoy Ex vivo testing of emulsification of different oils Cologne<br />
including<br />
Densiron HV<br />
5 min defer<br />
1424-1430 Hakan Kaymak Clinical experience with the Siluron 2000 Sulzbach/<br />
Saar<br />
5 min defer<br />
1430-1435 M Mura Siluron 2000 in the treatment of complex<br />
vitreoretinal detachment using 25 gauge<br />
transconjunctival vitrectomy<br />
Amsterdam 5 min defer<br />
1435-1450 Discussion of above 4 papers 15 min<br />
1450-1455 Norbert Kociok F4H5 Human experience in removing adherent Düsseldorf<br />
oil on Intraocular lenses<br />
5 min defer<br />
1455-1500 Theodor Stappler Can we remove adherent oil completely with<br />
F4H5?<br />
Liverpool 5 min defer<br />
1500-1510 Stanislao Rizzo Experience with F4H5 Pisa 10 min defer<br />
1510-1520 Discussion of above 3 papers 15 min<br />
1520-1530 Peter Szurman New Hydrogel Vitreous Substitute Tuebingen 5 min 5 min<br />
1530-1540 Kugler Wilfried Thermosensitive polymers as vitreous<br />
substitute<br />
Fluoron 5 min 5 min<br />
1540-1545 Mike Garvey An eyeful of s<strong>and</strong> Liverpool 5 min 5 min<br />
1545-1555 David Wong<br />
1555-1620 Coffee Break<br />
Low Molecular Weight Silicone Infusion Hong Kong 5 min 5 min<br />
Session 4: Dealing with Complications - Chairperson Jan van Meurs<br />
1620-1627 Wison Heriot How to manage subretinal PFCL bubbles Melbourne 7 min defer<br />
1627-1634 Jerzy Mackiewicz " Subretinal PFCL-what to do?" Lublin 7 min defer<br />
1634-1640 Discussion of above 2 papers 6 min<br />
1640-1655 Jan van Meurs The relation of injury site, tamponade used <strong>and</strong> Rotterdam<br />
the incidence of PVR: Analysis of 250 patients<br />
10 min 5 min<br />
1655-1705 Marc Veckeneer An outbreak of sticky oil Rotterdam 5 min 5 min<br />
3
<strong>Abstract</strong>s<br />
Table of contents<br />
Heavy Silicone Oil (Densiron-68®) For Persistent Macular Holes....................................................................... 6<br />
A. Lappas, A. Caramoy, A.M.H. Foerster, B. Kirchhof 6<br />
Macular Hole Surgery with Inner Limiting Membrane Peeling, Endodrainage, <strong>and</strong> Heavy Silicone Oil<br />
Tamponade ............................................................................................................................................................... 7<br />
Annelies Schurams, Joachim van Calster, Peter Stalmans 7<br />
Surgical management of macular retinal detachment due to macular hole in high myopia ........................... 9<br />
Barbara Parolini, MD, Grazia Pertile MD 9<br />
Is Heavy Oil helpful for PVR? ................................................................................................................................ 10<br />
Heinrich Heimann 10<br />
Retrospective analysis of 67 patients with heavy silicone oil tamponade ....................................................... 11<br />
K.A. Becker, K. Engelmann 11<br />
Treatment of GRT without perfluorocarbon liquids............................................................................................ 12<br />
Hong Woon 12<br />
Ex vivo emulsification testing of different oils including Densiron 68 HV ........................................................ 13<br />
Albert Caramoy, Sabine Schröder, Sascha Fauser, <strong>and</strong> Bernd Kirchhof 13<br />
Siluron 2000 in the treatment of complex vitreoretinal detachment using 25 gauge transconjunctival<br />
vitrectomy. .............................................................................................................................................................. 14<br />
M.Mura 14<br />
Removal of heavy oil from the limbus under topical anaesthesia .................................................................... 16<br />
Xavier Valldeperas 16<br />
Tubeless Siphoning A Guide to the Removal of Heavy Silicone Oil .................................................................. 17<br />
T Stappler, R Williams, SK Gibran, E Liazos, D Wong 17<br />
Removal of Densiron-68 with 23-Gauge transconjunctival vitrectomy System. How is it possible? ............ 18<br />
Romano MR, Heimann H, Groenwald C, Stappler T, Wong D. 18<br />
Increasing the extensional viscosity of Silicone oil reduces the tendency for emulsification ....................... 19<br />
Rachel L Williams, Michael Day, Michael J Garvey, Robert English <strong>and</strong> David Wong 19<br />
Can we remove adherent oil completely with F4H5? ......................................................................................... 20<br />
Stappler, R. Williams, D. Wong 20<br />
Clinical Experience with Siluron 2000.................................................................................................................. 21<br />
4
Hakan Kaymak 21<br />
Heavy Silicone Oil versus St<strong>and</strong>ard Silicone Oil in as vitreous tamponade in Inferior PVR (HSO Study): Interim<br />
Analysis of 94 consecutive patients..................................................................................................................... 22<br />
Antonia M. Joussen, Christina Ocklenburg, Bernd Kirchhof, Norbert Schrage, Ralf-Dieter Hilgers, on behalf of<br />
the HSO –Study Group 22<br />
F4H5: Experiences in removing adherent silicon oil on intraocular lenses ..................................................... 23<br />
Norbert Kociok, Yong Liang, Monika Leszczuk, Wilfried Hiebl4, Bastian Theisinger, Anja Lux, <strong>and</strong> Antonia M.<br />
Joussen 23<br />
Hydrogel as Vitreous Substitute........................................................................................................................... 24<br />
Peter Szurman 24<br />
Management of retained perfluorocarbon liquids. ............................................................................................. 25<br />
Wilson J. Heriot 25<br />
Subretinal PFCL – what to do ? ............................................................................................................................ 26<br />
Jerzy Mackiewicz 26<br />
AN EYEFUL OF SAND – AN ALTERNATIVE HEAVY TAMPONADE..................................................................... 27<br />
M.J,Day, M.J.Garvey, T. Stappler, R.L.Williams <strong>and</strong> D. Wong 27<br />
Combined Phacoemulsification <strong>and</strong> heavy oil removal. .................................................................................... 28<br />
David Steel, Sunderl<strong>and</strong> Eye Infirmary, UK 28<br />
Short term tamponade using perfluorcarbon in the treatment of giant retinal tears. .................................... 29<br />
Andrew Chang 29<br />
The use of viscoelastics in vitreoretinal surgery ............................................................................................... 30<br />
Carlos Mateo M.D. 30<br />
An Outbreak of Sticky Oil ..................................................................................................................................... 31<br />
Marc Veckeneer 31<br />
Hydraulic Jump to Heavy Oil – No Need for Heavy Liquids ............................................................................... 32<br />
Thomas Theelen, Maurits A.D. Tilanus, <strong>and</strong> B. Jeroen Klevering 32<br />
COMBINATION OF TAMPONADE ......................................................................................................................... 33<br />
Stefano Zenoni, Natalia Comi, Piero Fontana 33<br />
Thermosensitive polymers as vitreous substitute.............................................................................................. 34<br />
Wilfried Kugler, Fluoron GmbH, 89077 Ulm, Germany 34<br />
HSO AS 1ST CHOICE IN COMPLICATED RETINAL DETACHMENT: CHECKMATE IN TWO MOVES! ............ 35<br />
Cesare Forlini MD*, Matteo Forlini MD**, Paolo Rossini MD* 35<br />
5
Heavy Silicone Oil (Densiron-68 ® ) For Persistent Macular Holes<br />
A. Lappas, A. Caramoy, A.M.H. Foerster, B. Kirchhof<br />
Dept. of Vitreo-Retinal Surgery<br />
University of Cologne<br />
Purpose: To evaluate the long term results after retreatment of patients with persisting<br />
macular holes with Densiron-68 ® .<br />
Materials <strong>and</strong> Methods: Twelve consecutive patients presented with persisting macular holes<br />
after conventional macular hole surgery including internal limiting membrane peeling <strong>and</strong> gas<br />
tamponade with SF6 (sulphur hexafluoride). They were retreated with Densiron-68 ® , that was<br />
removed after 1,5-4 months. Best-corrected visual acuity, slit lamp examination, binocular<br />
fundus examination <strong>and</strong> optical coherence tomography (OCT) were used for pre- <strong>and</strong><br />
postoperative evaluation.<br />
Patients were followed for 12 months.<br />
Results: The mean preoperative diameter of the full thickness macular holes was 502,25 μm<br />
(+/- 129,39 μm). After 12 months eleven out of twelve macular holes were still closed after<br />
treatment with the “heavy silicone oil” tamponade Densiron-68 ® . In one case the macular<br />
hole reopened after removal of Densiron-68 ® . Mean visual acuity improved from 20/250<br />
(1,07 +/- 0,22 logMAR) prior to retreatment with Densiron-68 ® to 20/160 (0,76+/- 0,27<br />
logMAR) 12 months postoperatively.<br />
Conclusion: We observed anatomical closure of persisting macular holes up to 12 months<br />
after retreatment with Densiron-68 ® . In one case, however, the persisting hole could not be<br />
closed, in another case the macular hole reopened. Mean visual acuity improved by 3 lines.<br />
6
Macular Hole Surgery with Inner Limiting Membrane Peeling,<br />
Endodrainage, <strong>and</strong> Heavy Silicone Oil Tamponade<br />
Annelies Schurams, Joachim van Calster, Peter Stalmans<br />
7
Surgical management of macular retinal detachment due to macular<br />
hole in high myopia<br />
Barbara Parolini, MD, Grazia Pertile MD<br />
Ospedale Sacro Cuore<br />
Negrar Verona Italy<br />
Background. Macular retinal detachment due to macular hole in high myopia is a real surgical<br />
challenge. The rate of recurrence is very high with any surgical strategy available.<br />
The need for an easier <strong>and</strong> efficient surgery is explored<br />
Methods. Two series of eyes operated with vitrectomy, posterior cortex peeling <strong>and</strong> ILM<br />
peeling were revised. Seventeen eyes were tamponated with silicone oil 1000 <strong>and</strong> 24 eyes<br />
were tamponated with Densiron.<br />
Results. The rate of permanent retinal detachment was 24% in the silicone oil group <strong>and</strong> 40%<br />
in the Denrison group. Eyes reoperated with revision of vitrectomy <strong>and</strong> Densiron tamponade<br />
failed. Eyes reoperated with Silicone oil tamponade succeded with one or two additional<br />
surgeries.<br />
In the majority of cases the retina finally reattached but the macular hole remained flat <strong>and</strong><br />
open.<br />
A new model of macular scleral buckle is also presented in combination of vitrectomy<br />
Conclusions. Densiron is not helpful in diminishing the number of reoperation for macular<br />
retinal detachment in high myopes. We encourage the use of scleral buckle in combination<br />
with vitrectomy to lower the rate of reoperations <strong>and</strong> to facilitate macular hole closure.<br />
8
Is Heavy Oil helpful for PVR?<br />
Heinrich Heimann<br />
Royal Liverpool University Hospital, UK<br />
heinrich.heimann@gmail.com<br />
Complicated rhegmatogenous retinal detachments (RRD) <strong>and</strong> redetachments of the inferior<br />
retina are the major indication for the use of heavy silicone oil (HSO) tamponades. Proliferative<br />
vitreoretinopathy (PVR) grade B or C is present in around 70% of such cases [Stappler T et<br />
al., Eye 2008, 22:1360]. Whilst some authors argue that HSO might be helpful in lowering the<br />
rate of postoperative PVR through immediate tamponade of large inferior breaks <strong>and</strong> retinal<br />
reattachment, there is also an contrary viewpoint that a PVR reaction could be stimulated by<br />
possible pro-inflammatory effects of HSO.<br />
A review of published series of HSO surgery for complicated RRD shows overall<br />
reattachment rates between 33% <strong>and</strong> 86% with the majority being around 70% primary<br />
success [Heimann H et al., Eye 2008, 22:1342]. Most redetachments were caused by PVR in<br />
the superior periphery. Final success rates varied between 71% <strong>and</strong> 100% with the majority<br />
being around 90% final success. Postoperative PVR can be seen in around 20% to 30% of<br />
these complicated cases. In contrast to conventional silicone oil tamponades, PVR<br />
redetachments occur mainly in the superior periphery when the HSO tamponade is in situ.<br />
Newer HSO tamponades (Oxane HD <strong>and</strong> Densiron) do not seem to be associated with<br />
increased rates of intraocular inflammation.<br />
Conclusion: HSO is a useful tool for the treatment of inferior RRD associated with PVR.<br />
Postoperative PVR rates are comparable to conventional silicone oil tamponades. HSO<br />
tamponades seem to shift but not reduce PVR-stimulating factors. On the other h<strong>and</strong>, there<br />
is no indication that HSO tamponades have an additional PVR-stimulating effect. There is no<br />
published prospective r<strong>and</strong>omized clinical trial as yet to answer the question whether<br />
outcomes <strong>and</strong> complications of PVR surgery with HSO tamponades are better or worse<br />
compared to conventional silicone oil.<br />
9
Retrospective analysis of 67 patients with heavy silicone oil<br />
tamponade<br />
Department of ophthalmology, Klinikum Chemnitz gGmbH, Germany<br />
K.A. Becker, K. Engelmann<br />
Purpose: A retrospective analysis of 67 consecutive patients with heavy silicone oil<br />
tamponade (Densiron® 68).<br />
Patients <strong>and</strong> Methods: 67 patients with different indications underwent vitrectomy with<br />
Densiron® 68 tamponade from March 2006 to July 2009 at the department of<br />
ophthalmology, Klinikum Chemnitz gGmbH, Germany: 65 retinal detachements (thereof 6 due<br />
to diabetic retinopathy, 8 after trauma, 6 after previous intraocular surgery, 3 high myopic<br />
eyes), 1 low grade endophthalmitis <strong>and</strong> 1 massive subretinal bleeding due to ARMD. 7<br />
patients underwent a second Densiron® tamponade in the same eye.<br />
Results: The mean duration of the tamponade was 80±44 days (22-228d). We observed a<br />
“shift” phenomenon in 12 <strong>and</strong> significant emulsification in 6 patients. 29 of 67 patients<br />
underwent one or more prior surgeries before the Densiron® tamponade. In 39 patients only<br />
a removal of the heavy tamponade was performed thereafter. In 6 patients it was not possible<br />
to achieve a complete adherent retina. We observed no complications at the removal like<br />
“sticky” silicone oil.<br />
Conclusions: Heavy silicone oil tamponade have a great potential for the surgical treatment<br />
i.e. of complicated retinal detachement or after trauma. Further investigations <strong>and</strong> trials are<br />
necessary to reduce the rate or improve the treatment of “shift” phenomenon <strong>and</strong> to<br />
recommend indications.<br />
10
Treatment of GRT without perfluorocarbon liquids<br />
Hong Woon<br />
St James’ Hospital, Leeds UK<br />
We direct injected a heavy silicone oil (Densiron-68TM) into a fluid filled eye in the treatment of<br />
retinal detachments secondary to giant retinal tears (GRT). The technique uses the heavy<br />
silicone oil as a peroperative tool to unroll the GRT <strong>and</strong> to displace subretinal fluid. The<br />
densiron is then left to provide postoperative tamponade. It is thus a one step technique <strong>and</strong><br />
avoids the need to use a perfluorocarbon liquid in the treatment of GRT.<br />
The technique does not rely on the static hydrostatic forces generated by the displacement of<br />
fluid by the oil but on the dynamic forces generated by the injection of oil into the eye. The<br />
exp<strong>and</strong>ing oil bubble drives the contact line between oil, retina, <strong>and</strong> saline to displace<br />
subretinal fluid <strong>and</strong> flatten the retina. The role played by an advancing contact angle is<br />
discussed.<br />
11
Ex vivo emulsification testing of different oils including Densiron 68 HV<br />
Albert Caramoy, Sabine Schröder, Sascha Fauser, <strong>and</strong> Bernd Kirchhof<br />
University of Cologne, Center of Ophthalmology, Department of Vitreo-Retinal Surgery, 50924<br />
Cologne, Germany<br />
Corresponding author:<br />
Dr. med. Albert Caramoy<br />
University of Cologne<br />
Center of Ophthalmology<br />
Department of Vitreo-Retinal Surgery<br />
Kerpener Str. 62<br />
50924 Cologne<br />
Germany<br />
Tel: 0049 (0) 221 478-4308<br />
Fax: 0049 (0) 221 478-3526<br />
E-Mail: acaramoy@yahoo.co.uk<br />
ABSTRACT<br />
Purpose: To investigate whether the emulsification of conventional silicone oils can be<br />
reduced by adding small amounts of silicone molecules of very long chain length.<br />
Methods: Siluron 1000, Siluron 2000, Siluron 5000, Acri.Sil-Ol® 5000, Oxane® 5700,<br />
Densiron 68 LV, Densiron 68, <strong>and</strong> Densiron 68 HV (0.5 ml) were each tested along with either<br />
plasma or serum (0.5 ml) in a glass cuvette. Emulsification was induced by sonication <strong>and</strong><br />
documented by photography. The total area of emulsified oil was assessed using the ImageJ<br />
software.<br />
Results: The addition of small amounts of very long-chain silicone molecules significantly<br />
reduced the emulsification rate for 1000 cSt silicone oil (Siluron 2000) <strong>and</strong> for 1000 cSt<br />
silicone oil with admixture of F6H8 (Densiron 68 HV).<br />
Conclusion: New low-viscosity silicone oils show reduced emulsification similar to 5000 cSt<br />
oils. In future, it may be possible to avoid using 5000 cSt oils. The findings may foster silicone<br />
oil surgery in general <strong>and</strong> particularly the application of small-incision techniques.<br />
12
Siluron 2000 in the treatment of complex vitreoretinal detachment<br />
using 25 gauge transconjunctival vitrectomy.<br />
M.Mura<br />
Purpose: to determine feasibility, safety, efficacy of the new Siluron 2000, emulsification<br />
resistant silicone oil .<br />
Methods: 30 patients with complex retinal detachment were recruited.<br />
Inclusion criteria: retinal detachment with PVR requiring silicone oil infusion.<br />
Exclusion criteria: previous surgery involving silicone oil.<br />
All the patient underwent 25 gauge transconjunctival vitrectomy, membrane peeling,<br />
endolaser <strong>and</strong> retinectomy. Silicone oil was kept in the eye for a variable period of time<br />
pending on the indications ( range 15-91 days).<br />
Best corrected visual acuity pre <strong>and</strong> post operative, intraocular pressure 1 day, 1 week, 1<br />
month <strong>and</strong> 3 months post op <strong>and</strong> after oil removal were recorded.<br />
Intraocular inflammation was recorded post operatively <strong>and</strong> after oil removal according to the<br />
same time scheme.<br />
Silicone oil infusion <strong>and</strong> removal time were recorded.<br />
The presence <strong>and</strong> amount of emulsification was graded clinically 1 week, 1 month <strong>and</strong> 3<br />
months post-op before the oil is removed <strong>and</strong> 1 week after oil removal.<br />
Surgical outcome was also assessed.<br />
Results: All the patients had multiple inferior breaks with grade C PVR <strong>and</strong> higher. They all<br />
underwent 25 gauge transconjunctival vitrectomy, membrane peeling, retinectomy, laser <strong>and</strong><br />
Siluron 2000 oil infusion. Visual acuity improved from CF (range HM- 0.1) to 0.32 (range<br />
0.12-0.5).<br />
The oil was injected after a full air-fluid exchange, using a 25 gauge high-pressure infusion<br />
cannula ( Synergetics Inc.). The mean injection time was 68 seconds (range 65-70 sec.). 80<br />
to 90% oil fill was clinically seen the day after surgery. No intra or perioperative complications<br />
were encountered.<br />
In these patients the oil was removed after a mean period of 32 days after surgery (range<br />
15-91 days).<br />
Intraocular inflammation was very mild at day 1 ( trace to 1+ cells).<br />
Mean intraocular pressure was 13 mmHg (range 10-18 mmHg).<br />
No signs of emulsification were found on clinical examination with gonioscopy before <strong>and</strong><br />
after oil removal.<br />
The oil was removed via 25 gauge transconjunctival cannulas in a passive or active fashion.<br />
None of the 30 patients had subconjunctival oil extrusion. 3 patients developed central PVR<br />
without retinal detachment that was peeled at the same time of the oil removal. 2 patients<br />
redateched <strong>and</strong> required further surgical procedures.<br />
Conclusions: Siluron 2000 is a safe tamponade agent that can be efficiently used in<br />
association with 25 gauge surgical instruments. No signs of emulsification were found in this<br />
small group of patients.<br />
13
Removal of heavy oil from the limbus under topical anaesthesia<br />
Xavier Valldeperas<br />
Barcelona<br />
We present a case of an 89 year-old man who attended our clinic with a macula on retinal<br />
detachment (RD) in his right eye (RE), <strong>and</strong> total blindness in his left eye (LE) since child. Two<br />
weeks before, the patient had had a complicated cataract extraction in his RE, <strong>and</strong> the eye<br />
was left aphakic with a non-resolving vitreous haemorrhage.<br />
The patient developed a stroke during preoperative assessment in the anaesthetic<br />
department, <strong>and</strong> was immediately admitted <strong>and</strong> started on double antiaggregation with<br />
acetylsalicylic acid (75mg/day) <strong>and</strong> clopidogrel (100mg/day). Three days later, he underwent<br />
a pars plana vitrectomy (PPV) <strong>and</strong> heavy silicone oil - Densiron® - for the management of a<br />
macula on RD with an inferior giant retinal tear. The patient had this first PPV under subtenon<br />
anaesthesia <strong>and</strong> the direct supervision of the neurologist, who understood the need of urgent<br />
surgery in this case.<br />
Two months later, the retina was flat with a good laser scar, but a bubble of Densiron® had<br />
moved into the anterior chamber. We then decided to remove the endotamponade, in order<br />
to avoid corneal damage. The surgery was performed under topical anaesthesia, as the<br />
double antiaggregation was impossible to be stopped.<br />
We present the video of this procedure, when we removed the Densiron® through the limbus<br />
using a 20g paracentesis <strong>and</strong> an anterior chamber maintainer. The patient experienced no<br />
pain or discomfort at all, <strong>and</strong> the surgery was easy <strong>and</strong> safe to perform.<br />
14
Tubeless Siphoning A Guide to the Removal of Heavy Silicone Oil<br />
T Stappler, R Williams, SK Gibran, E Liazos, D Wong<br />
(1) St Pauls Eye Unit, Royal Liverpool University Hospital, Prescot St., Liverpool, L7 8XP, UK<br />
(2) Clinical Engineering <strong>and</strong> Ophthalmology, School of Clinical Sciences, University of<br />
Liverpool, Liverpool, UK<br />
(3) Eye Institute, LKS Faculty of Medicine, The University of Hong Kong<br />
Purpose: Heavy silicone oil removal can be challenging <strong>and</strong> differs considerably from<br />
conventional oil. Traditionally, strong active aspiration had to be applied through a long 18G<br />
needle just above the optic disc. We present a novel technique using a much shorter (7.5mm)<br />
<strong>and</strong> smaller (20G) needle allowing its removal “from a distance”.<br />
Method: Active aspiration on a vacuum of 600mmHg of the “viscous fluid injector” was<br />
applied using the 20G cannula in a polymethylmethacrylate model eye chamber that was<br />
surface-modified to mimic the surface properties of the retina. Measurements were taken<br />
using still photographs.<br />
Results: Under injection the maximum diameter of a silicone oil bubble supported by<br />
interfacial tension alone was 5mm for a steel <strong>and</strong> 7mm for a polyurethane cannula. Under<br />
suction, the silicone bubble changed shape <strong>and</strong> became conical thus further increasing the<br />
cannula’s reach. This conical shape illustrated “tubeless siphoning”, which is a physical<br />
property of non-Newtonian fluids.<br />
Discussion: Static forces such as the interfacial tension between the steel or plastic cannula<br />
<strong>and</strong> the oil, dynamic forces such as the phenomenon of tubeless siphoning inherent in the<br />
viscoelastic property of silicone made it feasible to use a shorter <strong>and</strong> smaller gauge needles<br />
to remove heavy silicone oil. We recommend the use of the short 20-gauge steel needle<br />
because it works <strong>and</strong> it reduces the risk of iatrogenic damage such as entry site tears or<br />
postoperative hypotony.<br />
15
Removal of Densiron-68 with 23-Gauge transconjunctival vitrectomy<br />
System. How is it possible?<br />
Romano MR, Heimann H, Groenwald C, Stappler T, Wong D.<br />
Affiliation:<br />
1 Royal Liverpool University Hospital, Liverpool, UK.<br />
2 Istituto Clinico Humanitas, Rozzano, Milan, Italy<br />
Purpose: to report a new approach for removal of Densiron-68 via pars plana<br />
with 23-Gauge transconjunctival sutureless vitrectomy system (TSVS).<br />
Methods: Prospective, interventional case series. Thirty-five eyes (21 phakic, 12<br />
pseudophakic, 2 Aphakic) of 35 patients underwent Densiron-68 (1480 mPas viscosity <strong>and</strong><br />
1.06 g/ml specific gravity) removal via pars plana with active suction of 600 mm Hg vacuum<br />
through a short 23-Gauge silicon cannula.<br />
Results: Densiron-68 was completely removed from all eyes. Retinal reattachment was<br />
achieved in all cases. The IOP was 19.8 (SD 3.5) mmHg at baseline, 11.2 (SD 4) mmHg at 1<br />
day postoperatively, <strong>and</strong> 12.4 (SD 2.9), 13.2 (SD 2.5), 15 (SD 1.8) mmHg after 1 week, 1<br />
month <strong>and</strong> 3 months, respectively. Seven eyes needed suture of at least one sclerotomy.<br />
Postoperative hypotony (≤ 8 mmHg) was seen in 3 out of 35 eye (5.7%) No additional<br />
postoperative procedure was necessary.<br />
Conclusions: Active removal of Densiron-68 with 23-Gauge short cannula is a simple,<br />
innovative <strong>and</strong> safe technique that can help reducing surgical trauma.<br />
16
Increasing the extensional viscosity of Silicone oil reduces the<br />
tendency for emulsification<br />
Rachel L Williams, Michael Day, Michael J Garvey, Robert English <strong>and</strong> David Wong<br />
Background: Emulsification of silicone oil tamponade agents can cause clinical complications. This<br />
study aimed to increase the emulsification resistance of silicone oil 1000 to be at least as resistant as<br />
silicone oil 5000 while maintaining the shear viscosity lower than 5000 mPa s to aid injection <strong>and</strong><br />
removal.<br />
Methods: High molecular weight (423 kDa) poly(dimethyl siloxane) was added to silicone oil 1000 at<br />
5% <strong>and</strong> 10% w/w concentration. The shear <strong>and</strong> extensional viscosity of 1000, 5000, a 50:50 mixture<br />
of 1000 <strong>and</strong> 5000 <strong>and</strong> 5% <strong>and</strong> 10% w/w additive blends of silicone oil were measured using capillary<br />
break-up extensional, rotational shear <strong>and</strong> capillary extrusion rheometry. In vitro emulsification was<br />
assessed qualitatively following agitation using Pluronic F68 or a protein solution as the emulsion<br />
stabiliser.<br />
Results: Addition of high molecular weight polymer increased the extensional viscosity of the blends at<br />
high strain rates to levels equal to or greater than silicone oil 5000. In all cases the shear viscosity of<br />
the blends was lower than that of silicone oil 5000. The additive blends were qualitatively as<br />
emulsification resistant as silicone oil 5000.<br />
Conclusion: Addition of low concentrations of very high molecular weight polymers of the same<br />
chemistry as the bulk oil has the potential to increase the emulsification resistance of the tamponade<br />
agents while maintaining ease of injection <strong>and</strong> removal.<br />
17
Can we remove adherent oil completely with F4H5?<br />
T. Stappler, R. Williams, D. Wong<br />
1St Paul’s Eye Unit, Royal Liverpool University Hospital, Liverpool, United Kingdom;<br />
2Clinical Engineering <strong>and</strong> Ophthalmology, University of Liverpool, Liverpool, United Kingdom;<br />
3Eye Institute, The University of Hong Kong, Hong Kong.<br />
<strong>Abstract</strong><br />
Purpose<br />
Adherent silicone oil on intraocular lenses (IOLs) following retinal detachment surgery induces<br />
large <strong>and</strong> irregular refractive errors, multiple images <strong>and</strong> gives rise to glare, distorted <strong>and</strong><br />
often poor vision. Its removal remains challenging often requiring mechanical wiping or<br />
explantation. F4H5 is a new semifluorinated alkane into which silicone oil is readily soluble.<br />
We aim to establish the effectiveness of F4H5 in removing silicone oil from three different<br />
types of IOL in vitro.<br />
Method<br />
Silicone lenses (PHARMACIA TECNIS ZM900), hydrophobic acrylic lenses (ALCON MA60)<br />
<strong>and</strong> PMMA lenses (OCULARVISION PMMA) were firstly immersed in phosphate buffered<br />
saline, secondly in silicone oil, then in F4H5 for 10 min <strong>and</strong> lastly vigorously agitated in F4H5<br />
for 1 minute. They were weighed at each stage using scales accurate to 0.0001g to measure<br />
the weight of the adherent oil. Dynamic contact angle analysis was used to assess their<br />
surface properties.<br />
Results<br />
Immersion in F4H5 alone removed 96.1%(±1.23) by weight of silicone oil from the<br />
hydrophobic acrylic lenses, 91.4%(±1.58) from the silicone <strong>and</strong> 95.6%(±1.44) from the<br />
PMMA IOLs. Immersion combined with 1 minute of agitation increased the removal to 98.8%<br />
(±0.46) from the acrylic IOLs, to 93.7%(±0.48) from the silicone IOLs <strong>and</strong> to 100% (within<br />
±0.0001g) from every PMMA IOL. After treatment with F4H5 all IOL were optically clear.<br />
Dynamic contact angle hysteresis curves remained permanently altered. All measurements<br />
were highly reproducible.<br />
Conclusion<br />
F4H5 was highly effective at removing the bulk of the silicone oil from all three groups of IOL.<br />
The dynamic contact angle measurements suggested that their surface properties were<br />
permanently modified.<br />
18
Clinical Experience with Siluron 2000<br />
Hakan Kaymak<br />
Purpose: The objective of this study was to test the applicability of the new silicone oil,<br />
Siluron 2000 in comparison with st<strong>and</strong>ard silicone oils, Siluron 1000 <strong>and</strong> Siluron 5000, with<br />
respect to small gauge surgery.<br />
Setting: Siluron 2000 is a Siluron 1000 / high molecular weight additive (2.500.000 mPas)<br />
blend with a viscosity of about 2000 mPas.<br />
Methods: To determine <strong>and</strong> compare the flow rates of silicone oil tamponades with different<br />
viscosities, the oils were pushed through cannulas of different size (20 Gauge, 20 G Kirchhof<br />
cannula, 23 Gauge, 25 Gauge) using a Geuder Megatron S3. In addition, different pressures<br />
were applied (1,5 bar, 3 bar, 6 bar). The amount of silicone oil was determined after 30<br />
seconds running time by weighing of the components. Every test was repeated ten times.<br />
Results: The flow rates of the various silicone oils tested were different depending on the<br />
cannula type. Interestingly, the flow rates showed a nonlinear course depending on the<br />
viscosity. In detail, Siluron 2000 is applicable through a 20 G cannula without any problems.<br />
This new silicone oil could also be utilized in a reasonable way through a 23 G <strong>and</strong> 25 G<br />
needle, however at a pressure of 6 bar. In comparison, the application of Siluron 1000 was<br />
easily done regardless of the conditions used. The applicability of Siluron 5000, however,<br />
even at 6 bar, decreases rapidly with decreasing cannula size.<br />
Conclusion: Siluron 2000 could be easily applied throught a 20 gauge needle. Importantly, its<br />
application through the smaller 23 <strong>and</strong> 25 gauge cannulas is much easier to perform<br />
compared to Siluron 5000.<br />
In addition, first clinical results with Siluron in 20 patients will also be presented.<br />
19
Heavy Silicone Oil versus St<strong>and</strong>ard Silicone Oil in as vitreous<br />
tamponade in Inferior PVR (HSO Study): Interim Analysis of 94<br />
consecutive patients<br />
Antonia M. Joussen, Christina Ocklenburg, Bernd Kirchhof, Norbert Schrage, Ralf-Dieter<br />
Hilgers, on behalf of the HSO –Study Group<br />
1 Department of Ophthalmology, University of Düsseldorf, Germany<br />
2 Department of Medical Statistics, RWTH Aachen, Germany<br />
3 Department of Vitreoretinal Surgery, Center of Ophthalmology, University of Cologne,<br />
Germany<br />
4 Augenklinik Köln-Merheim, Köln, Germany<br />
Objective: The Heavy Silicone Oil versus St<strong>and</strong>ard Silicone Oil Study (HSO-study) is<br />
designed to answer the question, whether a heavier than water tamponade improves the<br />
prognosis of eyes with PVR of the lower retina.<br />
Design: The HSO Study is a multicentre, r<strong>and</strong>omized, prospective controlled clinical trial<br />
stratified by surgeon comparing two endotamponades within a two arm parallel group<br />
design.<br />
Patients: Patients with inferiorly <strong>and</strong> posteriorly located PVR grade C-A6 were r<strong>and</strong>omized to<br />
either heavy silicone oil or st<strong>and</strong>ard silicone oil as a tamponading agent.<br />
Main Outcome Measures: The main endpoint criteria are complete retinal attachment at<br />
twelve months <strong>and</strong> change of VA twelve months postoperatively as compared to the<br />
preoperative VA.<br />
Results: 46 patients treated with heavy silicone oil were compared to 47 patients treated<br />
with st<strong>and</strong>ard silicone oil. There was no difference among the groups regarding baseline data.<br />
Three patients in the HSO <strong>and</strong> 5 patients in the st<strong>and</strong>ard silicone oil group fulfilled<br />
intraoperative exclusion criteria. There was no significant difference between both groups<br />
regarding anatomical success. Neither non-inferiority nor superiority was shown with regard<br />
to final acuity.<br />
Conclusions: The HSO Study is the first r<strong>and</strong>omised prospective clinical trial to compare<br />
heavy <strong>and</strong> st<strong>and</strong>ard silicone oil in patients with PVR of the lower retina. The interim results<br />
failed to demonstrate a superiority of a heavy tamponade.<br />
Clinical Trial<br />
Multicenter Study<br />
R<strong>and</strong>omized Controlled Trial<br />
20
F4H5: Experiences in removing adherent silicon oil on intraocular<br />
lenses<br />
Norbert Kociok, Yong Liang, Monika Leszczuk, Wilfried Hiebl4, Bastian Theisinger, Anja<br />
Lux, <strong>and</strong> Antonia M. Joussen<br />
1 Department of Ophthalmology, University of Düsseldorf, Germany<br />
2 Department of Ophthalmology, Peking University, People’s Hospital, PR China<br />
3 Department of Ophthalmology, University of Lublin, Pol<strong>and</strong><br />
4 Fluoron GmbH, Neu-Ulm, Germany<br />
<strong>Abstract</strong><br />
Purpose:<br />
We compared the efficacy of perfluorobutylpentane (F4H5) <strong>and</strong> perfluorohexyloctane (F6H8)<br />
in dissolving silicone oil from the surface of silicone intraocular lenses.<br />
Methods:<br />
Droplets of stained silicone oil applied to an object slide either lying flat or tilted by 30° was<br />
mixed with H2O, F4H5, or F6H8 <strong>and</strong> documented by a digital camera. Droplets of silicone oil<br />
were applied to silicone lenses <strong>and</strong> washed off by repeated rinsing with F4H5 or F6H8. A<br />
total of 11 patients with silicone lenses <strong>and</strong> silicone oil remnants on the posterior IOL surface<br />
were rinsed intraoperatively with F4H5 during removal surgery.<br />
Results:<br />
Only F4H5 was able to mix with silicone oil <strong>and</strong> to remove it form the surface of a glass object<br />
slides. Rinsing with 25 µl F4H5 reduced the amount of silicone oil 1000 mPas or 5000 mPas<br />
attached on a silicone lens to 15 % <strong>and</strong> 28%, respectively. A hanging droplet of silicone oil<br />
5000 beneath a silicone lens was completely removed from below by F4H5. In all patients a<br />
sufficient IOL cleaning was possible using F4H5. There was no significant postoperative<br />
inflammation in the vitreous or anterior chamber.<br />
Conclusion:<br />
Silicon oil dissolves effectively in F4H5 due to its lipophilic chemical structure. A much smaller<br />
volume of F4H5 than F6H8 is able to completely remove silicone oil from silicone lenses<br />
without applying intense mechanical forces. Intraocular use of F4H5 is safe <strong>and</strong> first clinical<br />
data underlines the effectiveness as a cleaning agent after contact of silicone lenses with<br />
silicone oil.<br />
Norbert Kociok, PhD<br />
Department of Ophthalmology<br />
University of Düsseldorf<br />
Moorenstr. 5<br />
40225 Düsseldorf<br />
Phone: +49 211 8104561<br />
Fax: +49 211 8117963<br />
Norbert.Kociok@uni-duesseldorf.de<br />
21
Hydrogel as Vitreous Substitute<br />
Peter Szurman<br />
Department of Ophthalmology, Eberhard-Karls University Tübingen, Germany<br />
The natural vitreous is a highly hydrated fibrillary composite with unique biophysical<br />
properties. Since more than 100 years considerable efforts have been made to develop an<br />
artificial vitreous substitute. But since today no ideal tamponade material has been available<br />
yet. The main desired properties comprise a sufficient tamponade effect without buoyancy,<br />
advantageous rheological parameters in view of viscosity, pseudoplasticity, cohesiveness,<br />
transparency <strong>and</strong> refraction stability, a good biocompatibility <strong>and</strong> biodegradability, shock<br />
absorption, no proliferation scaffold <strong>and</strong> potentially serving as a slow release system for<br />
antiproliferative drugs.<br />
Current tamponade materials fulfill these dem<strong>and</strong>s only in part by following a different<br />
strategy compared to the effect of the natural vitreous. They rather act by surface tension <strong>and</strong><br />
buoyancy. One should take into account that both properties do not represent the<br />
biomechanical action of the natural vitreous. Current research strategies rather follow the<br />
concept to mimic the properties of the natural vitreous by developing hydrogel polymers as<br />
vitreous substitute. The first prototypes of these hydrogels have been tested in animal<br />
experiments <strong>and</strong> seem to achieve these desired properties indicating that this might be a<br />
future strategy in retinal detachment surgery.<br />
22
Management of retained perfluorocarbon liquids.<br />
Wilson J. Heriot<br />
Retained perfluoro-carbon liquid droplets remain a frustrating post-operative complication in<br />
a small group of patients.<br />
Management of this complication is dependent on the location of the droplets: only subfoveal<br />
droplets are visually significant <strong>and</strong> should be removed.<br />
A study of the risk factors for retained PFCL (1) assessed 72 cases <strong>and</strong> found submacular<br />
droplets in 11.1% of eyes. There was no difference between perfluorodecalin <strong>and</strong> perfluoro<br />
n-octane. The most significantly associated risk factor was the presence of a large peripheral<br />
retinotomy (all cases had retinotomy of 120° or larger). Subretinal PFCL was found in 40% of<br />
eyes with a 360° retinotomy. Small <strong>and</strong> medium-sized retinal breaks were not associated with<br />
PFCL retention. BSS rinse during fluid-air exchange correlated significantly with subretinal<br />
PFCL- only 1 of 23 eyes that were rinsed had subretinal PFCL, although many had large<br />
retinotomies. The presence of subretinal PFCL does not seem to affect visual outcome nor<br />
the anatomical success when located outside the macula.<br />
Two main approaches have been reported: aspiration of the droplet or displacement within a<br />
localised detachment. Aspiration of the droplet can be performed directly thru a microcanula<br />
(2) or following BSS injection to create a subretinal fluid bleb. Alternatively, simply creating a<br />
BSS bleb that facilitates inferior displacement of the droplet is also successful.<br />
3 illustrative cases will be discussed.<br />
(1) Garcia-Valenzuela, Ito, Abrams. Retina 2004 24: 746.<br />
(2) Garcia-Arumi et al. BJO 2008 92:1693-4<br />
23
Subretinal PFCL – what to do ?<br />
Jerzy Mackiewicz<br />
Department of Ophthalmology, Medical University of Lublin, Pol<strong>and</strong><br />
Insufficient release of retinal traction or misdirected injection of preretinal PFCL into a retinal<br />
break can result in intraoperative subretinal PFCL. It is not very rare complication of<br />
vitreoretinal surgery <strong>and</strong> postoperative retention of subretinal PFCL occurs, according to the<br />
literature, in up to 17% of cases.<br />
Author discussed different cases of subretinal PFCL from his own practice. Small<br />
extramacular bubbles of subretinal PFCL have not been removed <strong>and</strong> during follow up did<br />
not affect retinal function. In cases of PFCL location very close to the fovea, repeat vitrectomy<br />
with small retinotomy <strong>and</strong> drainage was performed. Clinical pictures, OCT scans <strong>and</strong> follow<br />
up will be presented.<br />
24
An Eyeful of S<strong>and</strong> - an alternative heavy tamponade<br />
M.J,Day, M.J.Garvey, T. Stappler, R.L.Williams <strong>and</strong> D. Wong<br />
Silicone oil was first introduced as a possible tamponade agent in 1958. It fulfils many of the<br />
requirements of a tamponade agent. It is highly hydrophobic <strong>and</strong> therefore forms an interface<br />
with aqueous <strong>and</strong> the hydrophilic retina. Its specific gravity is slightly lower than water (0.98)<br />
<strong>and</strong> therefore it floats on top of the remaining aqueous but only low buoyancy forces apply,<br />
<strong>and</strong> so it is effective for treating retinal tears in the superior section of the vitreous cavity. Its<br />
viscosity can be varied by controlling the molecular weight.<br />
In a number of projects we have closely investigated the behaviour of silicone oil using an in<br />
vitro eye model which has been effective at demonstrating how the specific gravity of<br />
tamponade agents controls their behaviour. This has been instrumental in the development of<br />
a tamponade agent called Densiron which consists of a mixture of silicone oil with higher<br />
density perfluorohexyloctane. There are some concerns, however, over the long term stability<br />
of this tamponade agent <strong>and</strong> its increased tendency to emulsify in the eye. Hence, a clinical<br />
need exists for an alternative heavy tamponade.<br />
The current project builds on this background expertise. In order to increase the specific<br />
gravity of existing tamponade agents it is necessary to add a material of higher density. Since<br />
the addition of low molecular weight polymers with a different chemistry is undesirable,<br />
colloidal or nanoparticulate silica was identified as an additive which would not only increase<br />
the density but also, if finely dispersed, would not increase the optical turbidity. Alternatively,<br />
to ensure the maintenance of optical clarity the refractive index of the silicone fluid<br />
(polydimethylsiloxane) could be adjusted to match that of the silica by the addition of<br />
polydiphenylsiloxane.<br />
Our current prototype is a dispersion of 11% nanoparticle silica in poly phenylmethylsiloxane<br />
with has a viscosity of 2000 mPa.s <strong>and</strong> a specific gravity of 1.11. The dispersion is noncytotoxic<br />
<strong>and</strong> currently undergoing animal testing.<br />
25
Combined Phacoemulsification <strong>and</strong> heavy oil removal.<br />
David Steel, Sunderl<strong>and</strong> Eye Infirmary, UK<br />
Combined phaco <strong>and</strong> st<strong>and</strong>ard silicone oil removal is a widely adopted <strong>and</strong> successful<br />
technique avoiding the need <strong>and</strong> morbidity of sclerostomy creation. Two modifications of the<br />
technique to allow safe <strong>and</strong> efficient heavy oil removal will be described - one using an<br />
angled cannula with translceral illumination to allow endoviewing during oil removal <strong>and</strong> one<br />
using a short wide bore cannula without endoviewing. Potential pitfalls <strong>and</strong> tips for success<br />
will be discussed.<br />
26
Short term tamponade using perfluorcarbon in the treatment of giant<br />
retinal tears.<br />
Andrew Chang<br />
PhD FRANZCO FRACS<br />
Vitreoretinal Unit<br />
Sydney Eye Hospital<br />
This paper will report <strong>and</strong> describe our experience with short term heavy liquid tamponade in<br />
the treatment of giant retinal tears. At the Sydney Eye Hospital, the st<strong>and</strong>ard technique for<br />
the repair of these detachments involves short term heavy liquid tamponade.<br />
A retrospective series of 62 eyes is presented.<br />
Aim: To determine the efficacy <strong>and</strong> safety of perfluorocarbon liquid as a short term<br />
postoperative tamponade in patients with retinal detachment from giant retinal tears. Method:<br />
A retrospective consecutive case series of patients with retinal detachment from giant retinal<br />
tears who underwent vitrectomy using perfluorocarbon liquid as a short term postoperative<br />
internal tamponade. The perfluorocarbon liquid was removed 5–14 days (mean 7.5 days)<br />
later <strong>and</strong> replaced by gas or silicone oil. Scleral buckling was performed in some cases with<br />
proliferative vitreoretinopathy. The crystalline lens was removed if there was interference with<br />
the surgical view or if it was subluxated. The success rate of retinal reattachment, visual<br />
outcome, <strong>and</strong> postoperative complications were assessed.<br />
Results: A total of 62 eyes of 61 patients with a follow up of 8–69 months (mean 24.5<br />
months) were included. All retinas were attached intraoperatively. 14 eyes (22.6%) developed<br />
re-detachment <strong>and</strong> additional operations were performed in 13 eyes. At final visit, 58 eyes<br />
(93.5%) had retinas that remained attached with visual acuity 6/12 or better in 27 eyes<br />
(46.5%). The visual acuity improved in 34 eyes (54.8%) with 28 eyes (45.2%) improving at<br />
least two Snellen lines, it was unchanged in 20 eyes (32.3%), <strong>and</strong> was worse in eight eyes<br />
(12.9%). Three patients developed glaucoma that was controlled medically. There was no<br />
retained perfluorocarbon liquid in any eyes.<br />
Conclusion: Perfluorocarbon liquid appears safe <strong>and</strong> effective to use as a short term<br />
postoperative tamponade in management of retinal detachment from giant retinal tears.<br />
However In the past 12 months we have encountered a more intense inflammatory reaction<br />
in 2 patients. Keratic precipitates <strong>and</strong> preretinal deposits developed over the period in which<br />
the heavy liquid is retained in the eye. Following removal of the heavy liquid the inflammatory<br />
reaction rapidly resolved.<br />
27
The use of viscoelastics in vitreoretinal surgery<br />
Carlos Mateo M.D.<br />
Perfluorocarbon liquids were described for its ophthalmological use as a manipulator during<br />
vitreoretinal surgery in nineteen eighty seven by Stanley Chang .<br />
The main characteristics of these Newtonian compounds are<br />
Low viscosity :from 0.8 to 8 Centistokes at 25° C<br />
They are clear<br />
Specific gravity higher than saline<br />
In early seventies Balazs suggested Sodium Hyaluronate as a substitute for vitreous .This<br />
compound has been commonly used in the anterior segment surgery , <strong>and</strong> also to manage<br />
the anterior chamber during vitreoretinal surgery ,to open <strong>and</strong> maintain the pupil ...or for<br />
example to help to stabilize a strange foreign body in the anterior chamber....<br />
Sodium hyaluronate (1%; Healon) has the most favorable viscoelastic properties.<br />
Its molecular weight is nearly 4 million daltons<br />
These compounds are Non Newtonian fluids with pseudoplasticity<br />
Shearing occurs when fluid is made to flow. At zero shear rate (steady state) they exhibit high<br />
viscocity , 400.000Cks whereas at high shear rates their viscocity decreases near to 110<br />
centistokes.<br />
This behaviour allows the material to be injected through small gauge cannula <strong>and</strong> yet<br />
ensures that the material will regain its shape , <strong>and</strong> they are cohessive , maintain spaces <strong>and</strong><br />
permit easy aspiration .<br />
All these differences make viscoelastics , the material of choice to “open the Retinal<br />
Balloon”in severe traumatized eyes where the funnel shape of the retinal detachment<br />
prevents enough visualization of the posterior retina <strong>and</strong> in some special PVR cases with<br />
posterior breaks.<br />
In this presentation we show how to deal with these severe cases using viscoelastics..<br />
28
An Outbreak of Sticky Oil<br />
Marc Veckeneer<br />
"The laws of physics predict that removal of a silicone oil bubble form inside a water filled<br />
sphere with a hydrophilic surface should be straightforward.<br />
However, upset <strong>and</strong> mayhem can occur when the SiO turns into glue. Interactions with<br />
perfluorocabon liquids <strong>and</strong> other surface modifying agents can alter the surface energy of the<br />
bubble thereby increasing adherence to the retina <strong>and</strong> resistance to aspiration."<br />
29
Hydraulic Jump to Heavy Oil – No Need for Heavy Liquids<br />
Thomas Theelen, Maurits A.D. Tilanus, <strong>and</strong> B. Jeroen Klevering<br />
Background<br />
Perfluorocarbon liquids (PFCL) are frequently used to reattach the retina in vitrectomy for<br />
retinal detachment (RD). However, retained PFCL bubbles may cause visual disturbance <strong>and</strong><br />
can be the source of permanent visual loss if displaced subfoveal. Hydraulic jump is a<br />
physical phenomenon causing fluid movement against gravity by sudden change of fluid<br />
speed, which can be used to remove subretinal fluid.<br />
Patients <strong>and</strong> Methods<br />
Consecutive RD cases treated with heavy silicone oil (HSO; Densiron 68®) tamponade for<br />
inferior retinal tears, retinotomy, or PVR, between January 2007 <strong>and</strong> December 2008 were<br />
retrospectively studied. During pars plana vitrectomy the retina was reattached by the<br />
hydraulic jump technique (HYD; study group) or by PFCL (controls).<br />
Results<br />
A total of 237 eyes (64 cases, 173 controls) were studied. Mean duration of tamponade was<br />
9 <strong>and</strong> 10 weeks in HYD <strong>and</strong> PFCL, respectively. Mean duration of surgery was 34 minutes in<br />
HYD <strong>and</strong> 53 minutes in PFCL. There were somewhat more eyes with retinal traction due to<br />
PVR C in the HYD group than in the PFCL group (54.6% vs. 41.0%, respectively).<br />
Accordingly, primary success rates were 53% <strong>and</strong> 61% in the HYD <strong>and</strong> PFCL group,<br />
respectively. After a maximum of two surgeries, final reattachment of the retinal was reached<br />
in 86% of the HYD <strong>and</strong> in 84% of the PFCL group.<br />
Conclusion<br />
Reattaching the retina in complicated RD cases by hydraulic jump appears equal to PFCL<br />
use in terms of surgical success. By this technique, retained PFCL bubbles can be avoided<br />
<strong>and</strong> surgery may become faster <strong>and</strong> less expensive without sacrifying safety.<br />
30
COMBINATION OF TAMPONADE<br />
Stefano Zenoni, Natalia Comi, Piero Fontana<br />
Divisione Oculistica<br />
Azienda Ospedaliera “Ospedali Riuniti di Bergamo”<br />
Bergamo- Italy<br />
Introduction: primary <strong>and</strong> secondary proliferative vitreoretinopathy (PVR) is a dynamic<br />
biological phenomenon for which drugs of sure efficacy do not exist at present. Vitreous<br />
substitutes are used as stabilising substances that should limit the effects of proliferation <strong>and</strong><br />
the consequent retinal detachment. Double filling (DF) has been previously experienced with<br />
combinations of silicone oil (PDMS) <strong>and</strong> perfluorocarbonades (PFCL), PDMS <strong>and</strong><br />
fluorosilicone, PDMS <strong>and</strong> perfluorohexiyloctane (F6H8), PDMS <strong>and</strong> perfluorooctane (HPF8). In<br />
selected cases of retinal detachment (RD) with high degree PVR we used a mixture of 70%<br />
heavy silicone oil (Densiron) <strong>and</strong> 30% PDMS as temporary vitreous substitute after pars plana<br />
vitrectomy (PPV). This in order to tamponade inferior <strong>and</strong> superior retinal breaks for the first<br />
seven days <strong>and</strong> to fill completely the vitreous cavity, reducing compartimentalisation. The aim<br />
of this presentation is to test the stability of this DF mixture <strong>and</strong> to evaluate its clinical efficacy.<br />
Methods: two laboratory tests were performed. In the first one we evaluated the properties of<br />
the mixture <strong>and</strong> the interface presence between the two substances, in the second one we<br />
evaluated the interface persistence between the two tamponades after shaking. For the<br />
laboratory tests, the silicone oil was coloured for better visualisation.<br />
Fifty consecutive eyes of fifty patients affected by complicated RD with retinal breaks of the<br />
superior <strong>and</strong> inferior quadrants associated with high degree PVR underwent PPV, retinal<br />
reattachment, membrane peeling <strong>and</strong> a combined internal tamponade with 70% Densiron<br />
<strong>and</strong> 30% PDMS. The DF was removed after an average of 55 days (range 45
Thermosensitive polymers as vitreous substitute<br />
Wilfried Kugler, Fluoron GmbH, 89077 Ulm, Germany<br />
For a long time ophthalmologists are searching for a biocompatible <strong>and</strong> bioactive vitreous<br />
substitute to improve post-operative treatment in vitreoretinal surgery.<br />
Aim of our joint project is the development <strong>and</strong> preparation of biocompatible, thermosensitive<br />
hydrogels. The hydrogel is liquid at room temperature <strong>and</strong> can be injected using conventional<br />
needles <strong>and</strong> syringes. As the hydrogel warms to body temperature it gelatinises <strong>and</strong> unfolds<br />
its endotamponade effect. By-<strong>and</strong>-by it is metabolized. In a first approach we want to link<br />
thermo-responsive block co-polymers to a biopolymer, hyaluronic acid. Important material<br />
properties, among others, should be transparency, stability, as well as a suitable surface<br />
tension <strong>and</strong> transition temperature. Technical challenges to be solved include sterilisability,<br />
im- <strong>and</strong> explantability as well as the filling process. The main objective of our work is to<br />
demonstrate that hyaluronic acid-based thermosensitive hydrogels can be utilized as vitreous<br />
substitute.<br />
32
HSO As 1ST Choice In Complicated Retinal Detachment: Checkmate<br />
In Two Moves!<br />
Cesare Forlini MD*, Matteo Forlini MD**, Paolo Rossini MD*<br />
(*) Unit of Ophthalmology “S. Maria delle Croci” Hospital, Ravenna - Italy<br />
(*) Eye Clinic, Univeristy of Modena – Italy<br />
INTRODUCTION: Silicone oil is a vitreous substitute used routinely during vitreo-retinal<br />
surgery as a tamponade during retinal detachment (R.D.) treatment, complicated by vitreoretinal<br />
proliferation (PVR). Such substance, due to its specific weight lower than 1, if used in a<br />
aqueous ambient, tends to float over the the water’s surface. This intrinsic property<br />
represents an advantage, in vitreo-retinal surgery, as it allows the silicone bubble to<br />
tamponade the retinal break present in the superior retina, for a large lapse of time, using<br />
therefore silicon oil as an alternative to the shor-medium term tamponading mixture air & gas.<br />
In the other h<strong>and</strong>, in presence of pathological situations that include central <strong>and</strong> inferior retinal<br />
sectors, tamponading action with the mentioned agent is notably lower to patients in clino/<br />
orthostatic posture.<br />
In fact, for that purpose it is well known in cases of complicated R.D. (non recent R.D., posttraumatic,<br />
associated to PDR), the risk to develop PVR in the “dead space” is present where<br />
an aqueous film between the silicon oil bubble’s margin <strong>and</strong> the retinal surface. In this space<br />
accumulate pigmented epithelia cells that trigger from inside the under - epiretinal<br />
proliferation action.<br />
As the use of st<strong>and</strong>ard silicone oil (1000-5000 centistokes) demonstrated such phenomena is<br />
generally located at the inferior sectors, because of the above mentioned oil’s own physic<br />
property of “floating” (fig. 1).<br />
Trying to overcome on such inconvenient, there have been used several procedures to obtain<br />
an adequate tamponade action on the inferior retina.<br />
At first only with liquid perfluorocarbon (PFCL, F6H8), later on with double tamponade (PFCL/<br />
F6H8-silicone oil) an finally with the last generation of heavy silicon oil (HSO), to fight back the<br />
proliferation in the inferior sectors, cause of recurrence <strong>and</strong> therefore surgery’s fail.<br />
Actually we can count on several ways to treat superior retinal breaks (air, gas, silicon oil).<br />
Unfortunately all these having a specific weight C3)<br />
were trated with heavy silicon oil (Densiron 68, Fluoron).<br />
33
Surgical Technique: 23 gauge transconjunctival vitrectomy (Alcon Accurus 2500, Dorc<br />
Associate 2500) with te use of Xenon ch<strong>and</strong>elier light system (Dorc Brightstar, Synergetics<br />
Photon 2) positioned at 12 o’clock or at 6, depending on the case; all phakic patients<br />
become pseudophakic, to be able to access easily to the extreme retinal periphery. Assisted<br />
triamcinolone vitrectomy with accurate shaving of the vitreous base; peeling of eventual<br />
epiretinal <strong>and</strong> subretinal membranes (if present) with bimanual technique with the help of a<br />
ch<strong>and</strong>elier light illumination source.<br />
For all patients, routinely we perform an ILM peeling, prior staining (in fluid or PFCL) with ICG<br />
or Brilliant Peel; use of endolaser on present break(s) <strong>and</strong> at 360°; direct PFCL-HSO<br />
exchange or prior air exchange. All scleral-accesses are always sutured at the end of the<br />
operation, with transconjuntival 7/8-0 suture.<br />
HSO is maintained within a period among 60 <strong>and</strong> 90 days. The removal is performed through<br />
the active aspiration (vacuum 500-600 mmHg) with 20 or 23 gauge transconjuntival system<br />
(fig.4). A very meticulous control to the retinal periphery is done, <strong>and</strong> epiretinal membrane<br />
peeling if present, always using illumination source with ch<strong>and</strong>elier system.<br />
RESULTS: Recurrence at the superior retina was present in 7 cases (30%) between 9 <strong>and</strong> 3<br />
o’clock, at the moment of the second procedure performed among 60-90 days from the first<br />
operation. In 3 cases it was used 1000 cs oil, in 4 cases gas mix (C2F6 15%). Of the 3 cases<br />
were tamponade with 1000cs oil 2 cases had to be reoperated with the use of 1000 cs oil.<br />
4 cases are highlighted of essudation in anterior chamber over the anterior <strong>and</strong> posterior<br />
surface of the IOL, associated to increase of intraocular pressure, all well controlled with<br />
medical therapy.<br />
CONCLUSIONS: The choice of HSO Densiron 68, associated to the ILM routine peeling, has<br />
avoided R.D. recurrence episodes or PVR at inferior sectors <strong>and</strong> at the posterior pole (in any<br />
case, no macular secondary pucker was encountered). HSO does not oblige the patient to<br />
uncomfortable posing.<br />
All cases of PVR were reallocated to the superior emiretina (9/3 o’clock). In R.D. recurrence<br />
cases, it was possible to operate with diversified solutions with silicone oil <strong>and</strong> gas mixture,<br />
always on patient’s behalf.<br />
The surgical strategy has allowed to reduce further operations with reallocating critic area to<br />
superior sectors <strong>and</strong> to manage recurrence more easily (using different tamponade<br />
substances) <strong>and</strong> interrupting the multiple inferior recurrence chain.<br />
Due to our experience, it is absolutely important to check out some solutions during the<br />
surgical phase of the primary vitrectomy as follows:<br />
allocating service sclerotomies close to horizontal meridians, to facilitate operation at the<br />
superior sectors.<br />
Use an independent ch<strong>and</strong>elier light system to execute bimanual manoeuvre <strong>and</strong> an accurate<br />
shaving of the vitreous base <strong>and</strong> peripheral retinopexy.<br />
ILM peeling using vital dyes with the help of PFCL if a R.D. is present<br />
Anterior segment complications observed were always treated with medical therapy <strong>and</strong> we<br />
never need to remove the HSO before the scheduled time.<br />
Finally, the strategy of using HSO as first choice in case of complicated R.D. allows to ensure<br />
the anatomical <strong>and</strong> functional success in two passages: checkmate in two moves!<br />
Images.<br />
34
Fig. 1: scheme of the “dead space” localized in the inferior quadrants developed with<br />
st<strong>and</strong>ard silicone oil endo-tamponade.<br />
Fig. 2: scheme of the “dead space” localized in the superior quadrants developed with HSO<br />
endo-tamponade.<br />
Fig. 3: HSO active aspiration with 23 gauge cannula.<br />
Fig. 4: epiretinal membrane developed in the superior nasal sector after HSO tamponade in a<br />
post-traumatic case<br />
35